Roche’s Gazyva Approved in the U.S. – Analyst Blog
Roche ( RHHBY ) is a leader in oncology drugs with strong demand for breast cancer drugs like Herceptin, Perjeta …read more
Roche ( RHHBY ) is a leader in oncology drugs with strong demand for breast cancer drugs like Herceptin, Perjeta …read more
Wells Fargo & Company ( WFC ) announced a settlement with the Federal Housing Finance Agency (FHFA) conservator …read more
Moody’s Investors Service, the credit rating division of Moody’s Corp. ( MCO ), has reiterated certain ratings on three Indian …read more
By Robert FitzPatrick What possibly could be said further about Herbalife ( HLF )? It has been dissected in every …read more
On Nov 5, we maintained a Neutral recommendation on Apollo Group Inc. ( APOL ) despite surprisingly strong fourth quarter …read more
Google Inc. ( GOOG ) recently announced expansion plans for its data center in Southern Finland to meet the fast …read more
Bringing in innovation for its tech friendly mobile shoppers Macy’s, Inc. ( M ) is set to integrate NantMobile’s iD …read more
Shire plc ( SHPG ) announced positive top line results from two phase III studies on attention deficit and hyperactivity …read more
American States Water Company ( AWR ) reported third quarter 2013 pro forma earnings of 53 cents per share, beating …read more
Domestic energy explorer, Comstock Resources Inc. ( CRK ) reported third quarter adjusted loss per share (from continuing operations) of …read more